MAPK1 and leukemia: Key pharmacological targets identified for the protective effects of vitamin C against PFOS-associated leukemia include tumor protein p53 (TP53), mitogen-activated protein kinase 1 (MAPK1), and estrogen receptor 1 (ESR1) [81].